Blended care to discontinue benzodiazepine receptor agonists use in patients with chronic insomnia disorder: a pragmatic cluster randomized controlled trial in primary care

STUDY OBJECTIVES: International guidelines recommend using benzodiazepine receptor agonists (BZRA) for maximally four weeks. Nevertheless, long-term use for chronic insomnia disorder remains a common practice. This study aimed to test the effectiveness of blended care for discontinuing long-term BZR...

Descripción completa

Detalles Bibliográficos
Autores principales: Coteur, Kristien, Henrard, Gilles, Schoenmakers, Birgitte, Laenen, Annouschka, Van den Broeck, Kris, De Sutter, An, Anthierens, Sibyl, Devroey, Dirk, Kacenelenbogen, Nadine, Offermans, Anne-Marie, Van Nuland, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Insomnia and Psychiatric Disorders
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091092/
https://www.ncbi.nlm.nih.gov/pubmed/36413221
http://dx.doi.org/10.1093/sleep/zsac278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091092/
https://www.ncbi.nlm.nih.gov/pubmed/36413221
http://dx.doi.org/10.1093/sleep/zsac278

Ejemplares similares